Vous n'êtes pas connecté
Aragen Life Science, formerly GVK Biosciences, secures a $100 million investment from healthcare-focused private equity fund Quadria Capital. The investment will support Aragen’s strategic expansion and infrastructure development to meet growing demand for outsourcing services from US and Europe innovators. This move positions Aragen strongly in the pharmaceutical outsourcing market, enhancing its capabilities and accelerating program delivery.
Moniepoint, Nigeria’s leading fintech company, has raised over $10 million in fresh funds from Visa, bringing its Series C funding total to more...
Workwize, a global leader in IT hardware asset management, has raised an impressive $13 million in Series A funding to fuel its vision of fully...
LemFi, the platform transforming how immigrant communities' access financial services, has raised $53 million in Series B funding led by Highland...
Following its investment, Visa will join Moniepoint’s board
Abu Dhabi-based edtech startup CodiPlay has secured $9 million in a Series A funding round at a valuation of $100 million. The funding round included...
Helsingborg-based HealthTech startup Xaga Surgical has raised € 700,000 (SEK 8 million) in an investment round to expand its operations to the U.S....
By Zhou Chao Since the Trump administration, the U.S. has gradually increased its restrictions and blockades on China in the field of high-tech...
AI startup Klang AI has raised € 260,000 in a new funding round, attracting investment from high-profile business angels. The funding will...